Pharmacological restoration and therapeutic targeting of the B-cell phenotype in classical Hodgkin lymphoma

Author:

Du Jing12,Neuenschwander Martin3,Yu Yong4,Däbritz J. Henry M.1,Neuendorff Nina-Rosa1,Schleich Kolja1,Bittner Aitomi1,Milanovic Maja1,Beuster Gregor4,Radetzki Silke3,Specker Edgar3,Reimann Maurice1,Rosenbauer Frank5,Mathas Stephan14,Lohneis Philipp6,Hummel Michael67,Dörken Bernd14,von Kries Jens Peter3,Lee Soyoung14,Schmitt Clemens A.147

Affiliation:

1. Medical Department of Hematology, Oncology, and Tumor Immunology, and Molekulares Krebsforschungszentrum, Charité - Universitätsmedizin Berlin, Berlin, Germany;

2. Center of Cancer Research, Binzhou Medical University Hospital, Binzhou, People’s Republic of China;

3. Screening Unit, Leibniz-Institut für Molekulare Pharmakologie, Berlin, Germany;

4. Max-Delbrück-Center for Molecular Medicine, Helmholtz Association, Berlin, Germany;

5. Institute for Molecular Tumor Biology, Westfälische Wilhelms-Universität, Münster, Germany;

6. Institute of Pathology, Charité - Universitätsmedizin Berlin, Berlin, Germany; and

7. Berlin Institute of Health, Berlin, Germany

Abstract

Key Points A pharmacological screening identified compounds that reactivate B-cell–specific gene expression in cHL cell lines. B-cell phenotype-restoring drug combinations render cHL cell lines susceptible to B-NHL–reminiscent targeted therapies.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3